The Pseudomonas Genome Database collaborates with an international panel of expert Pseudomonas researchers to provide high quality updates to the PAO1 genome annotation and make cutting edge genome analysis data available

Search Gene Annotations by Name

Exact Name Name Contains
Choose a specific strain (optional)
OR choose a species (optional)
Complete genomes only
Include draft genomes

Database Statistics

Complete Genomes 184
Draft Genomes 2376
Manually-curated annotation updates 3215
Curated GO terms 4365

Latest News

February 15, 2017
PseudoCyc metabolic pathway mappings updated to version 19.5 (link).
Format of hit sequence IDs in raw blast output changed to allow easier linking with other data sources. Each hit now contains locus tag, RefSeq accession and GI.
January 25, 2017
New release with updated annotations and 229 new Pseudomonas genomes (total of 2560 in database).
164 manually curated annotations updates including new genes, product names, and subcellular localizations.
13 curated Gene Ontology (GO) annotations added.
Updated 3D Structures from PDB.
New and/or updated KEGG pathways based on release 81.0 (January, 2017) for 93 strains including PAO1, PA14 and KT2440.
PseudoCyc metabolic pathway database contains new pathways and the software (PathwayTools) has been updated from version 16.5 to 19.5 to provide improved visualization, navigation and analysis tools.
November 15, 2016
Fixed issue with server error occurring for ncRNA gene annotations.
October 21, 2016
Added bug fixes for some instances where 3D structure and human homolog data was not being displayed or was returning an error.
More user-friendly visualization of orthologs. The top studied strains now appear at the beginning of the list, followed by alphabetical sorting by species/strain.

Strains and Isolates in the Database

Submit an annotation update

We welcome all suggested updates to Pseudomonas annotations and no registration is required!


PseudoCAP was the first wholly Internet-based and community-based genome annotation project for analysis of a genome of a free-living organism.

Current and past funding

Funding for this work is gratefully provided by Cystic Fibrosis Foundation Therapeutics Inc., a non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation.